Turbine (Biotechnology) Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
110
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$27M
- Investors
-
25
Turbine (Biotechnology) General Information
Description
Developer of cancer combination therapies designed to clarify the underlying biology of diseases and develop personalized therapies. The company's combination therapies leverage bioinformatics, network medicine, and artificial intelligence to reliably simulate complex interventions by screening millions of possible drug combinations on simulated cells, enabling cancer patients to receive a low-cost and effective cancer treatment plan.
Contact Information
Website
www.turbine.aiCorporate Office
- Szigony utca 26 32. A. lhaz 2 em
- Budapest, 1083
- Hungary
Corporate Office
- Szigony utca 26 32. A. lhaz 2 em
- Budapest, 1083
- Hungary
Turbine (Biotechnology) Timeline
Turbine (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series B) | 24-Feb-2026 | $27M | Completed | Generating Revenue | ||
| 8. Later Stage VC | 04-Oct-2024 | Completed | Clinical Trials - General | |||
| 7. Accelerator/Incubator | 01-Jan-2024 | Completed | Clinical Trials - General | |||
| 6. Later Stage VC (Series A) | 20-Jun-2023 | Completed | Clinical Trials - General | |||
| 5. Later Stage VC | 07-Jan-2021 | Completed | Clinical Trials - General | |||
| 4. Early Stage VC | 13-Nov-2019 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC | 01-Jan-2017 | Completed | Startup | |||
| 2. Accelerator/Incubator | $54.3K | Completed | Startup | |||
| 1. Accelerator/Incubator | 24-Nov-2016 | $54.3K | $54.3K | Completed | Startup |
Turbine (Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-4A Preferred | ||||||||
| Series B-4 Preferred | ||||||||
| Series B-3 Preferred | ||||||||
| Series B-2A Preferred | ||||||||
| Series B-1 Preferred | ||||||||
| Series B-2 Preferred | ||||||||
| Series A Peferred | ||||||||
| Series A Peferred | ||||||||
| Series A1 | 155,161 | $0.011850 | $3.94 | $3.94 | 1x | $3.94 | 0.71% | |
| Pre-Series A3 Preferred | 118,601 | $0.011850 | $3.15 | $3.15 | 1x | $3.15 | 0.54% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Turbine (Biotechnology) Comparisons
Industry
Financing
Details
Turbine (Biotechnology) Competitors (6)
One of Turbine (Biotechnology)’s 6 competitors is Freenome, a Formerly VC-backed company based in Brisbane, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Freenome | Formerly VC-backed | Brisbane, CA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Axion Biosystems | Private Equity-Backed | Atlanta, GA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA |
Turbine (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Turbine (Biotechnology) Patents
Turbine (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025074096-A1 | P97 (vcp) atpase inhibitors | Inactive | 02-Oct-2023 | ||
| US-20260077047-A1 | Cancer therapy | Pending | 05-Sep-2022 | ||
| WO-2024052663-A1 | Cancer therapy | Inactive | 05-Sep-2022 | ||
| EP-3897605-A1 | Combination therapy | Active | 24-Dec-2019 | ||
| EP-3897605-B1 | Combination therapy | Active | 24-Dec-2019 | A61K31/196 |
Turbine (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Turbine (Biotechnology) Investors (25)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beiersdorf | Corporation | Minority | ||
| Beiersdorf Venture Capital | Corporate Venture Capital | Minority | ||
| Crane Venture Partners | Venture Capital | Minority | ||
| Interactive Venture Partners | Venture Capital | Minority | ||
| Accenture Ventures | Corporate Venture Capital | Minority |
Turbine (Biotechnology) FAQs
-
When was Turbine (Biotechnology) founded?
Turbine (Biotechnology) was founded in 2015.
-
Where is Turbine (Biotechnology) headquartered?
Turbine (Biotechnology) is headquartered in Budapest, Hungary.
-
What is the size of Turbine (Biotechnology)?
Turbine (Biotechnology) has 110 total employees.
-
What industry is Turbine (Biotechnology) in?
Turbine (Biotechnology)’s primary industry is Biotechnology.
-
Is Turbine (Biotechnology) a private or public company?
Turbine (Biotechnology) is a Private company.
-
What is the current valuation of Turbine (Biotechnology)?
The current valuation of Turbine (Biotechnology) is .
-
What is Turbine (Biotechnology)’s current revenue?
The current revenue for Turbine (Biotechnology) is .
-
How much funding has Turbine (Biotechnology) raised over time?
Turbine (Biotechnology) has raised $65.3M.
-
Who are Turbine (Biotechnology)’s investors?
Beiersdorf, Beiersdorf Venture Capital, Crane Venture Partners, Interactive Venture Partners, and Accenture Ventures are 5 of 25 investors who have invested in Turbine (Biotechnology).
-
Who are Turbine (Biotechnology)’s competitors?
Freenome, Inovio Pharmaceuticals, Axion Biosystems, Kite Pharma, and Genetix Biotherapeutics are some of the 6 competitors of Turbine (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
